RxDoctor Payments Data

Jessica Whiteman, APRN

Nurse Practitioner · Saint Joseph, MONPI 1508477688

Payments from drug & device makers

$1,754in general payments, 2019–2025

Across 103 payments — averaging $17.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$313
  • Teva Pharmaceuticals USA, Inc.$184
  • Lilly USA, LLC$169
  • Otsuka America Pharmaceutical, Inc.$141
  • AstraZeneca$134
  • Lundbeck LLC$114
  • plus $698 from 23 others

What the payments were for

  • Food & beverage$1,754100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,754 in reported general payments places this provider in the 80th percentile of 1,898 nurse practitioner providers in Missouri.

See all nurse practitioner providers in Missouri

Medicare billing

Part B allowed, 2024
$1,785
Medicare patients
50
Services billed
139

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide28$36,227
XareltoRivaroxaban19$25,077
JardianceEmpagliflozin12$20,555
JanuviaSitagliptin Phosphate17$12,847
LinzessLinaclotide19$12,695
EliquisApixaban15$11,753
Tresiba Flextouch U-100Insulin Degludec14$9,872
Breo ElliptaFluticasone/Vilanterol21$9,255
Spiriva HandihalerTiotropium Bromide11$8,972
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr14$8,431
MyrbetriqMirabegron16$7,127
SymbicortBudesonide/Formoterol Fumarate20$5,159
Aripiprazole22$4,130
DuleraMometasone/Formoterol11$3,921
Albuterol Sulfate HfaAlbuterol Sulfate162$3,674

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$169$36,22728 claims
Johnson & JohnsonXarelto$22$25,07719 claims
Boehringer IngelheimJardiance$83$20,55512 claims
MerckJanuvia, Dulera$12$16,76928 claims
AbbVieLinzess$313$12,69519 claims
PfizerEliquis$15$11,75315 claims
Astellas Pharma US IncMyrbetriq$64$7,12716 claims
AstraZenecaSymbicort$134$5,15920 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,898 nurse practitioner providers in Missouri.

Other nurse practitioner in Saint Joseph

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →